GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible ...

Psychological interventions may be effective for achieving freedom from functional seizures, according to new practice ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

AI helped identify patients with drug-resistant epilepsy who might benefit from surgery, and it highlighted missing tests and ...

Apollo Cancer Centre successfully treats a 23-year-old's decade-long seizures using advanced, incision-free CyberKnife radiosurgery.

Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 ...

Taylor Hyma's journey from enduring drug-resistant epilepsy to becoming seizure-free after brain surgery highlights hope and ...

Nicola Swanborough, Head of External Affairs at Epilepsy Society said: “We welcome this much-needed overhaul which prioritises treatment for patients with urgent and complex dental requirements. This ...